0001231919-21-000051.txt : 20210601 0001231919-21-000051.hdr.sgml : 20210601 20210601162915 ACCESSION NUMBER: 0001231919-21-000051 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210601 DATE AS OF CHANGE: 20210601 EFFECTIVENESS DATE: 20210601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ajax Therapeutics, Inc. CENTRAL INDEX KEY: 0001780490 IRS NUMBER: 834655405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-401272 FILM NUMBER: 21985688 BUSINESS ADDRESS: STREET 1: 275 MADISON AVE, 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 646-361-0100 MAIL ADDRESS: STREET 1: 275 MADISON AVE, 39TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001780490 Ajax Therapeutics, Inc. 275 MADISON AVE, 39TH FLOOR NEW YORK NY NEW YORK 10016 646-361-0100 DELAWARE None None Corporation true 2019 Martin Vogelbaum c/o Ajax Therapeutics, Inc. 275 Madison Ave, 39th Floor New York NY NEW YORK 10016 Executive Officer Director Scott Platshon c/o Ajax Therapeutics, Inc. 275 Madison Ave, 39th Floor New York NY NEW YORK 10016 Director Ramy Farid c/o Ajax Therapeutics, Inc. 275 Madison Ave, 39th Floor New York NY NEW YORK 10016 Director Ross Levine c/o Ajax Therapeutics, Inc. 275 Madison Ave, 39th Floor New York NY NEW YORK 10016 Director Biotechnology Decline to Disclose 06b false 2021-05-17 false true false 0 40000000 37382554 2617446 false 14 0 0 0 false Ajax Therapeutics, Inc. /s/Martin Vogelbaum Martin Vogelbaum Chief Executive Officer 2021-06-01